Orthopedic Cement Injection Technology Acquired by Vexim
Written by Heather Linder | February 28, 2013
Vexim has acquired a system to mix and inject orthopedic cement for vertebroplasty procedures. The technology will be incorporated into the company’s SpineJack implant, a minimally invasive device for treatment of vertebral compression factures. The orthopedic cement technology will allow Vexim to expand its presence in vertebroplasty. Injecting cement into the vertebra will also allow surgery to be performed on cases where stabilizing the fracture and eliminating pain are priorities, according to the report. The system is scheduled to launch simultaneously in Europe and the U.S. in 2014.
Mergers and Acquisitions 2013
By Madeleine Armstrong, Editor, Business In order to keep track of the busy medtech mergers
In order to keep track of the busy medtech mergers and acquisitions market, Clinica brings to you its ‘live’ M&A table. Featuring the latest transactions in the medical device arena, the table features all pending and closed deals of 2012 so far.
Vexim acquires new cement injector for vertebroplasty
By AMANDA PEDERSEN – Medical Device Daily Senior Staff Writer
Vexim (Toulouse, France), a company developing technology for vertebral fractures, said it has acquired a new orthopedic cement injection system for its development in vertebroplasty. The company had already made its mark in the space with its SpineJack implant, a device designed to treat vertebral compression fractions in a minimally invasive way, enabling the anatomic restoration of fractured vertebra and the reestablishment of the spinal column’s balance.
Vexim acquires new technology
Elizabeth Hofheinz, M.P.H., M.Ed. • Wed, March 6th, 2013
Vexim, a French company focused on the minimally invasive treatment of vertebral fractures, has announced the acquisition of an innovative technological system in the injection of orthopedic cement for its development in vertebroplasty. The system was developed by Altavance, a Swiss company.
Vexim’ s 2012 growth confirms SpineJack adoption in Europe
Medical Industry Week | 18/01/2013
Vexim , a Toulouse , France-based company focused on developing minimally–invasive products to treat traumatic spinal pathologies , has reported its sales for the second half and full-year 2012 financial results.
European Markets for Spinal Implants and VCF
Scottrade | 06/02/2013
Reportlinker.com announces that a new market research report is available in its catalogue: The European spinal implant market is expected to exceed EUR 1 billion by 2018. Growth in the interbody fusion device segment will continue to be the largest contributor to the rising spinal implant market.
February 5, 2013
January 13, 2013